leucine and Cognitive Decline

leucine has been researched along with Cognitive Decline in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's7 (87.50)2.80

Authors

AuthorsStudies
Aboseif, A; Galioto, R; Krishnan, K; Kunchok, A; Lace, J1
Han, S; Hu, N; Jin, Y; Li, B; Shang, X; Wang, J; Wang, S1
Han, L; Liu, X; Shi, R; Wang, B; Wang, D; Wang, L; Xia, B; Ye, J; Zhao, B; Zhao, Z1
Amaral, AP; Conde, R; Graça, G; Morais, E; Oliveira, N; Sousa, A; Verde, I1
Beiler, K; Bowser, LE; Brigatti, KW; Carson, VJ; Chopko, S; Haas-Givler, B; Hailey, J; Heaps, AD; Hendrickson, C; Loeven, K; Mazariegos, GV; Morton, DH; Muelly, ER; Puffenberger, EG; Radcliff, Z; Robinson, DL; Rodrigues, A; Shellmer, DA; Soltys, K; Strauss, KA; Taylor, CM; Williams, KB; Young, ME1
Hiraki, K; Hishida, Y; Kawanabe, S; Nagai, Y; Sone, M; Tanaka, Y; Yamamoto, Y1
Binks, SNM; Easton, A; Husain, M; Irani, SR; Leite, MI; Okai, D; Veldsman, M1
Kishida, D; Miyazaki, D; Sato, M; Sekijima, Y1

Trials

1 trial(s) available for leucine and Cognitive Decline

ArticleYear
Effects of resistance training using elastic bands on muscle strength with or without a leucine supplement for 48 weeks in elderly patients with type 2 diabetes.
    Endocrine journal, 2021, Mar-28, Volume: 68, Issue:3

    Topics: Aged; Cognition; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Hand Strength; Humans; Leucine; Male; Muscle Strength; Organ Size; Resistance Training; Walking Speed

2021

Other Studies

7 other study(ies) available for leucine and Cognitive Decline

ArticleYear
Cognitive outcomes in anti-LGI-1 encephalitis.
    Journal of the International Neuropsychological Society : JINS, 2023, Volume: 29, Issue:6

    Topics: Adult; Aged; Cognition; Cognitive Dysfunction; Encephalitis; Epilepsy, Temporal Lobe; Female; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Male; Neuropsychological Tests; Retrospective Studies

2023
Case Report: Paroxysmal weakness of unilateral limb as an initial symptom in anti-LGI1 encephalitis: a report of five cases.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Cognitive Dysfunction; Dementia; Glioma; Humans; Leucine; Seizures

2023
Leucine-Restricted Diet Ameliorates Obesity-Linked Cognitive Deficits: Involvement of the Microbiota-Gut-Brain Axis.
    Journal of agricultural and food chemistry, 2023, Jun-21, Volume: 71, Issue:24

    Topics: Animals; Bacteria; Brain-Gut Axis; Cognition; Cognitive Dysfunction; Diet; Diet, High-Fat; Fatty Acids, Volatile; Firmicutes; Humans; Leucine; Mice; Mice, Inbred C57BL; Obesity

2023
NMR analysis seeking for cognitive decline and dementia metabolic markers in plasma from aged individuals.
    Journal of pharmaceutical and biomedical analysis, 2024, Jan-20, Volume: 238

    Topics: Acetone; Aged; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Glutamates; Histidine; Humans; Isobutyrates; Isoleucine; Leucine; Magnetic Resonance Spectroscopy; Tyrosine; Valine

2024
Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
    Molecular genetics and metabolism, 2020, Volume: 129, Issue:3

    Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Adolescent; Adult; Amino Acids, Branched-Chain; Biomarkers; Child; Child, Preschool; Cognitive Dysfunction; Cohort Studies; Diet; Female; Homozygote; Humans; Infant; Leucine; Liver Transplantation; Male; Maple Syrup Urine Disease; Mental Disorders; Middle Aged; Phenotype

2020
Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.
    JAMA neurology, 2021, 05-01, Volume: 78, Issue:5

    Topics: Antibodies; Autoantibodies; Cognition; Cognitive Dysfunction; Encephalitis; Fatigue; Glioma; Humans; Leucine

2021
A Patient with Limbic Encephalitis Associated with Anti-leucine-rich Glioma-inactivated 1 (LGI1) Antibody Presenting with Slowly Progressive Cognitive Impairment and Fluctuating Striatal Lesions.
    Internal medicine (Tokyo, Japan), 2019, Jan-15, Volume: 58, Issue:2

    Topics: Administration, Intravenous; Anti-Inflammatory Agents; Autoantibodies; Brain; Cognitive Dysfunction; Dementia; Diagnosis, Differential; Disease Progression; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Prednisolone; Proteins; Seizures

2019